South San Francisco, California
and Vancouver, Canada,
March 10, 2022 /CNW/ - ESSA Pharma
Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage
pharmaceutical company focused on developing novel therapies for
the treatment of prostate cancer, today announced that the Company
will be presenting at the virtual Oppenheimer 32nd
Annual Healthcare Conference on Thursday,
March 17, 2022 at 2:40 p.m. Eastern
Time.
David. R. Parkinson, President and Chief Executive Officer of
ESSA Pharma, will participate in and host one-on-one meetings.
Peter Virsik, ESSA's Chief Operating
Officer, and David S. Wood, ESSA's
Chief Financial Officer, will also be participating in the
one-on-one meetings.
Presentation Details
Presentation Date:
Thursday, March 17, 2022
Presentation Time:
2:40 p.m. ET
About ESSA Pharma Inc.
ESSA is a clinical-stage
pharmaceutical company focused on developing novel and proprietary
therapies for the treatment of patients with prostate cancer. For
more information, please visit www.essapharma.com and follow
us on Twitter under @ESSAPharma.
A webcast of the presentation can be accessed in the
Investors/Events & Presentations section of ESSA's website at
www.essapharma.com. Following the presentation, the webcast will be
archived for 90 days.
View original
content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-oppenheimer-annual-healthcare-conference-301499623.html
SOURCE ESSA Pharma Inc